Boehringer Ingelheim Pharmaceuticals Inc. et al v. Laurus Labs Ltd. et al
| Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH |
| Laurus Labs Ltd. and Laurus Generics Inc. |
| 1:2018cv01758 |
| November 7, 2018 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 3, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 12
Order Setting Scheduling Conference: A Scheduling Conference is set for 3/4/2019 at 02:30 PM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/3/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf)
|
| Filing 11 Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding coordinated discovery and Markman proceedings, and to request a scheduling conference. (Blumenfeld, Jack) |
|
Filing 10
ORDER, IT IS ORDERED that, on or before January 2, 2019, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/2/2019.) Signed by Judge Colm F. Connolly on 12/17/2018. Associated Cases: 1:18-cv-01689-CFC et al.(nmf)
|
|
SO ORDERED, re #9 STIPULATION TO EXTEND TIME to Answer Complaint to January 11, 2019 filed by Laurus Labs Ltd., Laurus Generics Inc., Set/Reset Answer Deadlines: Laurus Generics Inc. answer due 1/11/2019; Laurus Labs Ltd. answer due 1/11/2019. Signed by Judge Colm F. Connolly on 12/11/2018. (fms)
|
| Filing 9 STIPULATION TO EXTEND TIME to Answer Complaint to January 11, 2019 - filed by Laurus Generics Inc., Laurus Labs Ltd.. (Cole, Jeremy) |
| Filing 8 NOTICE of Appearance by Jeremy S. Cole on behalf of Laurus Generics Inc., Laurus Labs Ltd. (Cole, Jeremy) |
| Filing 7 DECLARATION of Mailing on Laurus Labs Ltd. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
| Filing 6 SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation. Laurus Generics Inc. served on 11/20/2018, answer due 12/11/2018. (Blumenfeld, Jack) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01757-CFC, 1:18-cv-01758-CFC, 1:18-cv-01762-CFC through 1:18-cv-01765-CFC, 1:18-cv-01779-CFC, 1:18-cv-01783-CFC, and 1:18-cv-01785-CFC through 1:18-cv-01789-CFC (rjb) |
| Summons Issued with Magistrate Consent Notice attached as to Laurus Generics Inc. on 11/8/2018; Laurus Labs Ltd. on 11/8/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (lak) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,449 B2 ;9,949,998 B2. (lak) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/27/2018. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 2/1/2022. (lak) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Laurus Generics Inc., Laurus Labs Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2499690.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation. (Attachments: #1 Exhibit 1-2, #2 Civil Cover Sheet)(lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
